Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Show more
Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0374 | 4.4 | 0.85 | 0.94 | 0.7919 | 352569 | 0.87382358 | CS |
| 4 | -0.6526 | -42.3766233766 | 1.54 | 1.7382 | 0.7043 | 745340 | 0.95149212 | CS |
| 12 | -1.4426 | -61.9141630901 | 2.33 | 2.52 | 0.7043 | 895672 | 1.49183113 | CS |
| 26 | -7.7726 | -89.752886836 | 8.66 | 9.395 | 0.7043 | 669402 | 2.67655434 | CS |
| 52 | -2.8326 | -76.1451612903 | 3.72 | 11.41 | 0.7043 | 661928 | 4.37860197 | CS |
| 156 | -11.1876 | -92.650931677 | 12.075 | 12.075 | 0.7043 | 365624 | 4.46534744 | CS |
| 260 | -13.5726 | -93.8630705394 | 14.46 | 18.67 | 0.7043 | 259453 | 5.53977644 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
